108 related articles for article (PubMed ID: 3664953)
1. Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis.
Enzmann H; Bannasch P
Carcinogenesis; 1987 Nov; 8(11):1607-12. PubMed ID: 3664953
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis.
Bannasch P; Hacker HJ; Klimek F; Mayer D
Adv Enzyme Regul; 1984; 22():97-121. PubMed ID: 6591771
[TBL] [Abstract][Full Text] [Related]
3. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
[TBL] [Abstract][Full Text] [Related]
4. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet.
Hacker HJ; Steinberg P; Bannasch P
Carcinogenesis; 1998 Jan; 19(1):99-107. PubMed ID: 9472700
[TBL] [Abstract][Full Text] [Related]
6. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
Goldfarb S; Pugh TD; Koen H; He YZ
Environ Health Perspect; 1983 Apr; 50():149-61. PubMed ID: 6873010
[TBL] [Abstract][Full Text] [Related]
7. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
Greaves P; Irisarri E; Monro AM
J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability.
Zerban H; Radig S; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1994 Nov; 15(11):2467-73. PubMed ID: 7955093
[TBL] [Abstract][Full Text] [Related]
9. Sequential changes in growth kinetics and cellular phenotype during hepatocarcinogenesis.
Zerban H; Rabes HM; Bannasch P
J Cancer Res Clin Oncol; 1989; 115(4):329-34. PubMed ID: 2760097
[TBL] [Abstract][Full Text] [Related]
10. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
[TBL] [Abstract][Full Text] [Related]
11. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1219-26. PubMed ID: 8020159
[TBL] [Abstract][Full Text] [Related]
12. Non-persisting early foci of altered hepatocytes induced in rats by N-nitrosomorpholine.
Enzmann H; Bannasch P
J Cancer Res Clin Oncol; 1988; 114(1):30-4. PubMed ID: 3350840
[TBL] [Abstract][Full Text] [Related]
13. Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
Grobholz R; Hacker HJ; Thorens B; Bannasch P
Cancer Res; 1993 Sep; 53(18):4204-11. PubMed ID: 8364915
[TBL] [Abstract][Full Text] [Related]
14. Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis.
Ribback S; Calvisi DF; Cigliano A; Sailer V; Peters M; Rausch J; Heidecke CD; Birth M; Dombrowski F
J Hepatol; 2013 Jun; 58(6):1147-56. PubMed ID: 23348238
[TBL] [Abstract][Full Text] [Related]
15. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
[TBL] [Abstract][Full Text] [Related]
16. [Malignant tendency of basophilic liver cells in experimental rat hepatocarcinogenesis].
Wang XM; Wang BE; Wang TL; Ou XJ; You H; Ma H; Jia JD
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):495-8. PubMed ID: 16867269
[TBL] [Abstract][Full Text] [Related]
17. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
[TBL] [Abstract][Full Text] [Related]
18. Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1.
Bannasch P; Benner U; Enzmann H; Hacker HJ
Carcinogenesis; 1985 Nov; 6(11):1641-8. PubMed ID: 2865015
[TBL] [Abstract][Full Text] [Related]
19. Biochemical microanalysis of pyruvate kinase activity in preneoplastic and neoplastic liver lesions induced in rats by N-nitrosomorpholine.
Klimek F; Bannasch P
Carcinogenesis; 1990 Aug; 11(8):1377-80. PubMed ID: 2387024
[TBL] [Abstract][Full Text] [Related]
20. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1235-42. PubMed ID: 8020161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
